Specificity of Effector Mechanisms in Syngeneic Graft-vs-Host Disease: Recognition of the MHC Class II Invariant Chain Peptide (CLIP)

By Hess A.   Thoburn C.   Bright E.   Horwitz L.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 725-727

Elsevier

Access to resources Recommend Favorite

Fluctuations in pathogenic CD4+ T-cell subsets in a murine sclerodermatous model of chronic graft-versus-host disease

By Lim Ji-Young   Cho Byung-Sik   Min Chang-Ki   Park Gyeongsin   Kim Yoo-Jin   Chung Nak-Gyun   Jeong Dae-Chul   Min Woo-Sung  

Immunological Investigations, Vol. 43, Iss. 1, 2014-01 ,pp. : 41-53

Informa Healthcare

Access to resources Recommend Favorite

An Analysis of Graft-Versus-Host Disease in Syrian Hamsters

By Streilein J. Wayne   Streilein J.  

Ocular Immunology and Inflammation, Vol. 15, Iss. 3, 2007-05 ,pp. : 165-177

Informa Healthcare

Access to resources Recommend Favorite

Protective Growth Factors for Graft-Versus-Host Disease

By  

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 5, Iss. 6, 2005-12 ,pp. : 565-573

Bentham Science Publishers

Access to resources Recommend Favorite

Depletion of activated alloreactive T cells in prevention of acute graft-versus-host disease

By Hu H.Z.   New J.Y.   Li B.   Chan S.H.   Yap E.H.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 2456-2457

Elsevier

Access to resources Recommend Favorite